Ray P, Sahoo N, Singh B, Kironde F A
Malaria Group, International Center for Genetic Engineering and Biotechnology, New Delhi, India.
Infect Immun. 1994 Jun;62(6):2354-61. doi: 10.1128/iai.62.6.2354-2361.1994.
We demonstrated that antibodies in the serum of BALB/c mice convalescent from Plasmodium yoelii infection inhibit the in vitro growth of Plasmodium falciparum. Blood stage P. falciparum antigens that cross-react with the convalescent-phase mouse serum antibodies were identified and partially characterized. Convalescent-phase mouse serum immunoglobulin G (IgG) reacted with P. falciparum lysates at up to a 1:15,000 dilution of the immune sera and bound to P. falciparum-parasitized erythrocytes at up to a 1:5,000 dilution of the sera. The cross-reactive moieties of antigens in parasite lysates were resistant to oxidation by periodate but sensitive to trypsinization. About 15 polypeptides (M(r)s of 15,000 to 110,000) of P. falciparum blood stages were recognized by the convalescent-phase mouse anti-P. yoelii sera; many of these antigens were metabolically 35S labeled and specifically immunoprecipitated. Also, virtually all of the cross-reactive antigens were recognized by human malaria-immune sera. The anti-P. yoelii serum antibodies bound, with high affinity, to at least five of the cross-reactive antigens (M(r)s of 107,000, 84,000, 53,000, 36,000, and 30,000). By phase separation in Triton X-114, eight interspecies cross-reactive antigens (M(r)s of 84,000, 76,000, 51,000, 31,000, 29,000, 28,000, 23,000, and 22,000) were found to be integral membrane proteins. Convalescent-phase mouse serum IgG strongly inhibited the differentiation of P. falciparum from schizonts to rings; 75 micrograms of IgG per ml caused 80% inhibition of release of merozoites and their invasion into erythrocytes. On the other hand, the anti-P. yoelii serum antibodies also inhibited intracellular development of P. falciparum from rings to schizonts; 25 micrograms of IgG per ml caused 50% inhibition. Inhibition of P. falciparum growth by anti-P. yoelii serum IgG suggests that some of the interspecies cross-reactive antigens contain important conserved epitopes and induce protective antibodies against P. falciparum.
我们证明,从约氏疟原虫感染中康复的BALB/c小鼠血清中的抗体可抑制恶性疟原虫的体外生长。鉴定并部分表征了与恢复期小鼠血清抗体发生交叉反应的恶性疟原虫血液期抗原。恢复期小鼠血清免疫球蛋白G(IgG)在免疫血清稀释至1:15,000时仍能与恶性疟原虫裂解物发生反应,并在血清稀释至1:5,000时与恶性疟原虫寄生的红细胞结合。寄生虫裂解物中抗原的交叉反应部分对高碘酸盐氧化具有抗性,但对胰蛋白酶处理敏感。恢复期小鼠抗约氏疟原虫血清可识别约15种恶性疟原虫血液期多肽(相对分子质量为15,000至110,000);其中许多抗原经代谢性35S标记并被特异性免疫沉淀。此外,几乎所有交叉反应抗原均可被人类疟疾免疫血清识别。抗约氏疟原虫血清抗体以高亲和力结合至少五种交叉反应抗原(相对分子质量为107,000、84,000、53,000、36,000和30,000)。通过在Triton X-114中进行相分离,发现八种种间交叉反应抗原(相对分子质量为84,000、76,000、51,000、31,000、29,000、28,000、23,000和22,000)为整合膜蛋白。恢复期小鼠血清IgG强烈抑制恶性疟原虫从裂殖体向环状体的分化;每毫升75微克IgG可导致80%的裂殖子释放及侵入红细胞的抑制。另一方面,抗约氏疟原虫血清抗体也抑制恶性疟原虫从环状体到裂殖体的细胞内发育;每毫升25微克IgG可导致50%的抑制。抗约氏疟原虫血清IgG对恶性疟原虫生长的抑制表明,一些种间交叉反应抗原含有重要的保守表位,并能诱导针对恶性疟原虫的保护性抗体。